Literature DB >> 1623060

Thrombotic thrombocytopenic purpura in early pregnancy with maternal and fetal survival.

E Rozdzinski1, B Hertenstein, T Schmeiser, E Seifried, E Kurrle, H Heimpel.   

Abstract

Thrombotic thrombocytopenic purpura (TTP) is a hematologic disorder which is clinically characterized by thrombocytopenia, microangiopathic hemolytic anemia, fever, neurologic symptoms, and cardiac and renal involvement. The pathogenic mechanisms of this disease are poorly understood. It is well known that TTP is associated with pregnancy and that prognosis for the mother and child is poor. We present the first case of a severe TTP diagnosed in the first trimester of pregnancy (13th week of gestation) with maternal survival and birth of a healthy child which required continuous and intensive treatment with plasma therapy until delivery. During a period of 24 weeks several attempts to discontinue plasma therapy failed because of continuous active disease, and it became evident that plasma infusions were not as effective as plasma exchanges. The fact that the patient entered into remission soon after delivery of a healthy child by cesarean section in the 37th gestational week shows that in this case pregnancy activated an unknown factor which does not cross the placenta and which can be removed by plasmapheresis.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1623060     DOI: 10.1007/bf01738304

Source DB:  PubMed          Journal:  Ann Hematol        ISSN: 0939-5555            Impact factor:   3.673


  22 in total

1.  Advances in the treatment of TTP.

Authors:  E G Taft
Journal:  Prog Clin Biol Res       Date:  1990

2.  Prostacyclin deficiency in thrombotic microangiopathy.

Authors:  G Remuzzi; L Imberti; G de Gaetano
Journal:  Lancet       Date:  1981 Dec 19-26       Impact factor: 79.321

3.  Presence of a platelet aggregating factor in the plasma of patients with thrombotic thrombocytopenic purpura (TTP) and its inhibition by normal plasma.

Authors:  E C Lian; D R Harkness; J J Byrnes; H Wallach; R Nunez
Journal:  Blood       Date:  1979-02       Impact factor: 22.113

4.  The detection of a platelet-agglutinating factor in thrombotic thrombocytopenic purpura.

Authors:  J G Kelton; J Moore; A Santos; D Sheridan
Journal:  Ann Intern Med       Date:  1984-11       Impact factor: 25.391

5.  Two successful pregnancies in a woman with chronic thrombotic thrombocytopenic purpura treated by plasma infusion.

Authors:  E C Lian; J J Byrnes; D R Harkness
Journal:  Am J Hematol       Date:  1984-04       Impact factor: 10.047

6.  Prostacyclin and thromboxane A2 in thrombotic thrombocytopenic purpura.

Authors:  S H Lee; J S Wainscoat; H Zeitlin; F G Bolton; H A Leaver; A Seawright; J M Preece
Journal:  Br Med J (Clin Res Ed)       Date:  1981-11-21

7.  Pregnancy complicated by thrombotic thrombocytopenic purpura with fetal sparing.

Authors:  S A Blakowski; L R Zacharski; M C Telfer
Journal:  Arch Intern Med       Date:  1983-11

Review 8.  Thrombotic thrombocytopenic purpura as a cause of thrombocytopenia in pregnancy: literature review.

Authors:  M G Pinette; A M Vintzileos; C J Ingardia
Journal:  Am J Perinatol       Date:  1989-01       Impact factor: 1.862

9.  Thrombotic thrombocytopenic purpura in pregnancy: response to plasma manipulations.

Authors:  J D Upshaw; T J Reidy; K Groshart
Journal:  South Med J       Date:  1985-06       Impact factor: 0.954

Review 10.  Thrombotic thrombocytopenic purpura: report of fourteen cases--occurrence during pregnancy and response to plasma exchange.

Authors:  V Caggiano; L P Fernando; J M Schneider; H C Haesslein; E J Watson-Williams
Journal:  J Clin Apher       Date:  1983       Impact factor: 2.821

View more
  2 in total

1.  Thrombotic microangiopathies.

Authors:  Mohamed Radhi; Shannon L Carpenter
Journal:  ISRN Hematol       Date:  2012-07-25

2.  Thrombotic thrombocytopenic purpura in the first trimester of pregnancy.

Authors:  Pooja Sikka; Seema Chopra; Neelam Aggarwal; Vanita Suri; Abi Chandrasekaran
Journal:  Asian J Transfus Sci       Date:  2013-01
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.